Article

An introduction to the structure and function of inflammatory mediators for clinicians.

Northwestern University Medical School, Chicago, Illinois, USA.
Clinics in Perinatology (impact factor: 2.46). 07/1995; 22(2):251-61. pp.251-61
Source: PubMed

ABSTRACT As is apparent from a brief overview of some of the more important mediators involved in perinatal physiology and disease states, basic science research has provided many clinically relevant observations that, as discussed in other articles in this issue, have resulted in the discovery and development of clinically effective medications used daily in the care of the gravid mother and her fetus or neonate. In addition, an excellent base for the understanding of the mechanisms of the physiology of the maternal-fetal-placental unit has been established via extensive general and more focused research involving mediators.

0 0
 · 
0 Bookmarks
 · 
19 Views
  • Source
    Article: Meconium stained fluid: approach to the mother and the baby.
    Michele C Walsh, Jonathan M Fanaroff
    [show abstract] [hide abstract]
    ABSTRACT: Meconium aspiration syndrome (MAS) is a common problem that most pediatricians will encounter in the delivery room and normal newborn nursery. Approximately 13% of all live births are complicated by meconium stained amniotic fluid (MSAF). MAS is defined as respiratory distress in an infant born through MSAF whose symptoms cannot be otherwise explained. Optimal care for an infant born through MSAF involves cooperation between the obstetrician and pediatrician, each with separate but imperative roles.
    Clinics in Perinatology 01/2008; 34(4):653-65, viii. · 2.46 Impact Factor
  • Source
    Article: Glucocorticoids in the treatment of neonatal meconium aspiration syndrome.
    Daniela Mokra, Juraj Mokry
    [show abstract] [hide abstract]
    ABSTRACT: Meconium aspiration syndrome is a serious neonatal disease with complex pathophysiology. With respect to the contribution of meconium-induced lung edema, inflammation and vasoconstriction on the course of the disease, glucocorticoids are increasingly used in the treatment of MAS despite the fact that principal questions on the choice of GCs derivative, mode of delivery and dosing have not been answered yet. To bring a complex insight into the topic, this article reviews the pathomechanisms of MAS, mechanisms of action of GCs, as well as the advantages and disadvantages of GCs administration in experimental models and newborns with MAS.
    European Journal of Pediatrics 04/2011; 170(12):1495-505. · 1.88 Impact Factor
  • Source
    Article: Controversies in the treatment of meconium aspiration syndrome.
    Steven L Gelfand, Jonathan M Fanaroff, Michele C Walsh
    [show abstract] [hide abstract]
    ABSTRACT: MAS remains an infrequent but challenging condition confronting neonatologists. Avoidance of postterm pregnancies, improved intrapartum monitoring,and amnioinfusion have been beneficial. Studies have not demonstrated conclusively that any form of ventilation is superior to others, but strategies that recruit alveoli are desirable. Surfactant lavage or replacement may be beneficial. When hypoxic respiratory failure progresses, iNO may improve oxygenation and avoid ECMO.
    Clinics in Perinatology 10/2004; 31(3):445-52. · 2.46 Impact Factor

Show more

Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

Keywords

apparent
 
brief overview
 
clinically effective medications
 
clinically relevant observations
 
disease states
 
excellent base
 
fetus
 
maternal-fetal-placental unit
 
perinatal physiology
 
physiology
 

J R Hageman